387:
He chaired and was a member of the Israel
National Committee for Biotechnology and other advisory committees on this subject. Among his major recommendations was the establishment of dedicated investment funds with the aid of government funding, a recommendation which is currently being implemented
350:
did not meet expectations. The lack of success in the trials provoked a negative response from the company's investors and the
Israeli media. Aviv left his position at Pharmos in 2007. However, these clinical trials remain to this day the largest trials performed in the field of pharmaceutical
365:, which are based on scientific research and clinical evidence. The products are marketed as snack bars and beverages under the brand Nutravida. The Functional Food segment is a rapidly growing field, which is expected to have a fundamental effect on population well-being.
299:
In 1980, Aviv initiated and started "Biotechnology
General Corp.", the first Israeli Biotechnology company focusing on Recombinant DNA (genetic engineering), which exists to this day. The foundation of the company was encouraged by
287:. The patented method he developed is used for the industrial production of growth hormone, in order to increase milk production by cows. Bovine growth hormone is in wide use in today's
570:
357:
As of 2011, Aviv focused his work in the company "Herbamed Ltd.", as chairman and major shareholder. Herbamed is an
Israeli company which develops health-supporting food products (
354:
In 2000, Aviv founded "Predix Corp.", which focused on development of pharmaceuticals using advanced computerization and three-dimensional algorithms, invented by Dr. Oren Becker.
368:
Other than his position at
Herbamed, Aviv also serves on the board of directors of Yeda Research and Development Company Ltd., which is the commercial arm of the
190:'s lab. In 1973 he returned to Israel, to the Weizmann Institute of Science, as a senior scientist and was then appointed associate professor with tenure.
580:
304:, formerly the president of Israel, and was supported by a group of investors led by Mr. Fred Adler, one of the leading Venture Capitalists.
166:, and planned a future in this field, almost with no connection to science. After completing an M.Sc. in The Faculty of Agriculture at the
373:
229:. This work was published in a series of papers, some of which were of the most quoted in the field of molecular biology for decades.
324:
167:
565:
369:
214:
183:
171:
103:
560:
174:
in
Rehovot. At first Aviv was interested in the study of plant biology, but he soon found himself fascinated with
268:
mechanisms. After his return to Israel, he continued to study the field of mRNA differentiation and synthesis.
253:
424:"Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose"
343:
162:, where he resided until his death in 2021. In his early twenties, he developed an interest in the field of
89:
217:, Aviv focused on the research of molecular processes related to differentiation, and synthesis control of
585:
347:
575:
237:
590:
494:
435:
307:
After he retired from "Biotechnology
General Ltd.", Aviv founded "Diatech Ltd." which specialized in
284:
276:
351:
treatment of head injury. Serious traumatic head injuries remain to this day a medical challenge.
398:
An editorial on the subject of "Bridging the Gap between Food and Health" written by Aviv in 2010
311:
tools, and "Pharmos Corp."- In which he served as chairman and CEO. Pharmos initially focused on
138:
industry in Israel, as he was widely involved in this industry since the late 1970s to this day.
319:), but was mostly known for its later work to develop an innovative drug invented by Professor
522:
463:
381:
320:
308:
261:
179:
175:
131:
77:
512:
502:
453:
443:
377:
312:
81:
397:
358:
272:
257:
119:
93:
498:
439:
301:
288:
222:
198:
517:
482:
458:
423:
554:
362:
233:
202:
151:
135:
85:
332:
265:
226:
187:
540:
336:
328:
163:
487:
Proceedings of the
National Academy of Sciences of the United States of America
428:
Proceedings of the
National Academy of Sciences of the United States of America
127:
448:
388:
with the foundation of two large-scale funds which include government aid.
526:
507:
467:
483:"In vitro synthesis of DNA complementary to purified rabbit globin mRNA"
260:'s lab he performed research which first made it possible to synthesize
316:
280:
245:
194:
159:
147:
49:
35:
134:. Aviv is considered to have a fundamental role in the shaping of the
218:
155:
60:
264:(cDNA), a method which was later widely used in the research of
249:
241:
402:
236:(mRNA) which enabled research of control mechanisms of the
126:) (born as Haim Greenspan in Romania, 1940) was an Israeli
178:. In 1970 Aviv completed his doctorate, which focused on
541:"Production of bovine growth hormone by microorganisms"
279:) and applied research, and produced a microorganism (
481:
Ross J, Aviv H, Scolnick E, Leder P (January 1972).
182:, and was offered a postdoctoral fellowship at the
99:
73:
56:
42:
28:
21:
271:During the late 1970s, Aviv entered the field of
232:Aviv developed a method for the purification of
158:at the age of ten. He was raised in the city of
571:Businesspeople in the pharmaceutical industry
295:Advancement of Israeli biotechnology industry
8:
205:. He also collected ancient Judaica books.
18:
516:
506:
457:
447:
376:and at several companies in the field of
170:, he began his doctorate studies in the
414:
7:
123:
374:Ben-Gurion University of the Negev
315:for the treatment of Eye disease (
14:
256:and tissues. In cooperation with
193:In his spare time, Aviv studied
130:who specialized in the field of
422:Aviv H.; Leder P. (June 1972).
325:Hebrew University of Jerusalem
168:Hebrew University of Jerusalem
1:
370:Weizmann Institute of Science
342:Despite promising results in
184:National Institutes of Health
172:Weizmann Institute of Science
104:Weizmann Institute of Science
581:Romanian emigrants to Israel
225:, under the guidance of Dr.
403:Website of Herbamed Company
154:) in 1940, and migrated to
607:
283:) containing the gene for
248:, and studied the role of
109:
66:
254:differentiation of cells
348:phase 3 clinical trials
344:Phase 2 clinical trials
90:Pharmaceutical industry
449:10.1073/pnas.69.6.1408
508:10.1073/pnas.69.1.264
285:Bovine Growth Hormone
186:(NIH) in the US, Dr.
566:Molecular biologists
313:development of drugs
499:1972PNAS...69..264R
440:1972PNAS...69.1408A
277:genetic engineering
213:During his work in
142:Birth and education
561:Israeli scientists
346:, the large scale
309:medical diagnostic
321:Raphael Mechoulam
262:complementary DNA
180:protein synthesis
176:molecular biology
146:Aviv was born in
132:molecular biology
113:
112:
78:Molecular Biology
68:Scientific career
16:Israeli scientist
598:
545:
544:
537:
531:
530:
520:
510:
478:
472:
471:
461:
451:
419:
378:drug development
359:Functional Foods
201:, especially of
125:
82:Drug development
19:
606:
605:
601:
600:
599:
597:
596:
595:
551:
550:
549:
548:
539:
538:
534:
480:
479:
475:
421:
420:
416:
411:
394:
382:medical devices
331:), a synthetic
297:
273:Recombinant DNA
258:Edward Scolnick
223:Immunoglobulins
211:
144:
94:Functional food
52:
47:
38:
33:
24:
17:
12:
11:
5:
604:
602:
594:
593:
588:
583:
578:
573:
568:
563:
553:
552:
547:
546:
532:
473:
434:(6): 1408–12.
413:
412:
410:
407:
406:
405:
400:
393:
392:External links
390:
363:Nutraceuticals
302:Ephraim Katzir
296:
293:
289:dairy industry
210:
207:
199:Jewish history
143:
140:
111:
110:
107:
106:
101:
97:
96:
75:
71:
70:
64:
63:
58:
54:
53:
48:
44:
40:
39:
34:
30:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
603:
592:
589:
587:
586:Living people
584:
582:
579:
577:
574:
572:
569:
567:
564:
562:
559:
558:
556:
542:
536:
533:
528:
524:
519:
514:
509:
504:
500:
496:
492:
488:
484:
477:
474:
469:
465:
460:
455:
450:
445:
441:
437:
433:
429:
425:
418:
415:
408:
404:
401:
399:
396:
395:
391:
389:
385:
383:
379:
375:
371:
366:
364:
360:
355:
352:
349:
345:
340:
338:
334:
330:
326:
322:
318:
314:
310:
305:
303:
294:
292:
290:
286:
282:
278:
274:
269:
267:
263:
259:
255:
251:
247:
243:
239:
235:
234:messenger RNA
230:
228:
224:
220:
216:
209:Academic work
208:
206:
204:
203:The Holocaust
200:
196:
191:
189:
185:
181:
177:
173:
169:
165:
161:
157:
153:
149:
141:
139:
137:
136:biotechnology
133:
129:
121:
117:
108:
105:
102:
98:
95:
91:
87:
86:Biotechnology
83:
79:
76:
72:
69:
65:
62:
59:
55:
51:
45:
41:
37:
31:
27:
20:
576:Israeli Jews
535:
493:(1): 264–8.
490:
486:
476:
431:
427:
417:
386:
367:
356:
353:
341:
306:
298:
270:
266:gene control
231:
227:Philip Leder
212:
192:
188:Philip Leder
145:
115:
114:
100:Institutions
67:
591:1940 births
337:head injury
329:Dexanabinol
238:translation
164:agriculture
57:Citizenship
555:Categories
409:References
333:canabinoid
339:victims.
335:to treat
323:from the
128:scientist
124:חיים אביב
116:Haim Aviv
23:Haim Aviv
527:4333043
495:Bibcode
468:4504350
436:Bibcode
317:Lotemax
281:E. coli
252:in the
246:protein
219:Globins
195:Judaism
160:Rehovot
148:Romania
50:Rehovot
36:Romania
525:
518:427588
515:
466:
459:426713
456:
372:, The
361:) and
156:Israel
120:Hebrew
74:Fields
61:Israel
523:PMID
464:PMID
380:and
250:mRNA
221:and
197:and
152:Arad
46:2021
43:Died
32:1940
29:Born
513:PMC
503:doi
454:PMC
444:doi
244:to
242:RNA
240:of
215:NIH
557::
521:.
511:.
501:.
491:69
489:.
485:.
462:.
452:.
442:.
432:69
430:.
426:.
384:.
291:.
122::
92:,
88:,
84:,
80:,
543:.
529:.
505::
497::
470:.
446::
438::
327:(
275:(
150:(
118:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.